Assessing the population-level prevention effect of emergency department-based HIV testing in the United States: A research framework and commentary

Annals of Emergency Medicine

Volumn 58, Issue 1 SUPPL., 2011, Pages

  Holtgrave, David R ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CONCEPTUAL FRAMEWORK; COST CONTROL; COST EFFECTIVENESS ANALYSIS; EMERGENCY CARE; EMERGENCY WARD; EVIDENCE BASED MEDICINE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV TEST; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MORBIDITY; MORTALITY; NOTE; PATIENT COUNSELING; PRIMARY PREVENTION; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; UNITED STATES; VIRUS TRANSMISSION;

EID: 79959421930     PISSN: 01960644     EISSN: 10976760     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2011.03.042     Document Type: Editorial

References (33)

1. Panel on Antiretroviral Guidelines for Adults and Adolescents Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents Department of Health and Human Services December 1, 2009; 1-161 http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL Accessed February 9, 2010
2. R.S. Janssen, D.R. Holtgrave, and R.O. Valdiserri The serostatus approach to fighting the HIV epidemic: prevention strategies for infected individuals Am J Public Health 91 2001 1019 1024 (Pubitemid 32574820)
3. Institute of Medicine Public Financing and Delivery of HIV/AIDS Care: Securing the Legacy of Ryan White 2004 National Academies Press Washington, DC
4. D.R. Holtgrave Costs and consequences of the US Centers for Disease Control and Prevention's recommendations for opt-out testing PLoS Med 4 2007 e194
5. Centers for Disease Control and Prevention Revised recommendations for HIV testing of adults, adolescents and pregnant women in health-care settings MMWR Recomm Rep 55 2006 1 17
6. A. Kecojevic, C. Lindsell, and M. Lyons Public health and clinic impact of increasing emergency department based HIV testing: perspectives from the 2007 Conference of the National Emergency Department HIV Testing Consortium Ann Emerg Med 58 2011 S151 S159
7. D.R. Holtgrave Written testimony on HIV/AIDS incidence and prevention Testimony before US House of Representatives Committee on Oversight and Government Reform (Chairman Henry A. Waxman) September 16, 2008
8. H. Hsu, and R.P. Walensky Cost-effectiveness analysis and HIV screening: the emergency medicine perspective Ann Emerg Med 58 2011 S145 S150
9. Centers for Disease Control and Prevention Emergency department visits http://www.cdc.gov/nchs/FASTATS/ervisits.htm Accessed February 7, 2010
10. N.J. Hudepohl, C.J. Lindsell, and K.W. Hart Impact of an ED HIV testing and screening program on the proportion of the ED population that has been tested Ann Emerg Med 58 2011 S140 S144
11. Kaiser Family Foundation HIV testing in the United States HIV/AIDS Policy Factsheet September 2006
12. Centers for Disease Control and Prevention Rapid HIV testing in emergency departmentsthree US sites, January 2005March 2006 MMWR Morb Mortal Wkly Rep 56 2007 597 601
13. J. Brown, R. Shesser, and G. Simon Routine HIV screening in the emergency department using the new US Centers for Disease Control and Prevention guidelines: results from a high-prevalence area J Acquir Immune Defic Syndr 46 2007 395 401 (Pubitemid 350098689)
14. G.D. Kelen, and R.E. Rothman Emergency departmentbased HIV testing: too little, but not too late Ann Emerg Med 54 2009 65 71
15. Centers for Disease Control and Prevention HIV prevalence estimatesUnited States, 2006 MMWR Morb Mortal Wkly Rep 57 2008 1073 1076
16. D.R. Holtgrave, and T. Anderson Utilizing HIV transmission rates to assist in prioritizing HIV prevention services Int J STD AIDS 15 2004 789 792 (Pubitemid 40018701)
17. G. Marks, N. Crepaz, and R.S. Janssen Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA AIDS 20 2006 1447 1450 (Pubitemid 43948252)
18. D. Holtgrave, H.I. Hall, and P.H. Rhodes Updated annual HIV transmission rates in the United States, 1977-2006 J Acquir Immune Defic Syndr 50 2009 236 238
19. H.I. Hall, R. Song, and P. Rhodes Estimation of HIV incidence in the United States JAMA 300 2008 520 529
20. Holtgrave D. Using transmission rates to understand incidence. Presented at: 2009 National HIV Prevention Conference; August 23-26, 2008; Atlanta, GA. Presentation B01-4.
21. C. Latkin, D. Donnell, and D.D. Celentano Relationships between social norms, social network characteristics, and HIV risk behaviors in Thailand and the United States Health Psychol 28 2009 323 329
22. Karon KM, Song R, Brookmeyer R, et al. Estimating HIV incidence in the United States from HIV/AIDS surveillance data and biomarker HIV test results. Stat Med. doi:10.1002/sim.3144.
23. Centers for Disease Control and Prevention HIV prevention in the United States: at a critical crossroads http://cdc.gov/hiv/resources/reports/pdf/hiv- prev-us.pdf Accessed February 9, 2010
24. Y.-H. Hsieh, J.J. Jung, and J.B. Shahan Outcomes and cost analysis of three operational models for rapid HIV testing services in an academic inner-city emergency department Ann Emerg Med 58 2011 S133 S139
25. P.G. Farnham, A.B. Hutchinson, and S.L. Sansom Comparing the costs of HIV screening strategies and technologies in health-care settings Public Health Rep 123 suppl 3 2008 51 62
26. D.U. Ekwueme, S.D. Pinkerton, and D.R. Holtgrave Cost comparison of three HIV counseling and testing technologies Am J Prev Med 25 2003 112 121 (Pubitemid 36918349)
27. Martin EG, Patiel AD, Walensky RP, et al. Expanded HIV screening in the US: what will it cost, and who will pay? a budget impact analysis. Presented at: Annual Meeting of the Society for Medical Decision Making; October 19, 2009; Los Angeles, CA.
28. R.P. Walensky, K.A. Freedberg, and M.C. Weinstein Cost-effectiveness of HIV testing and treatment in the United States Clin Infect Dis 45 suppl 4 2007 S248 S254
29. M.L. Brandeau, and G.S. Zaric Optimal investment in HIV prevention programs: more is not always better Health Care Manag Sci 12 2009 27 37
30. G.D. Sanders, A.M. Bayoumi, and V. Sundaram Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy N Engl J Med 352 2005 570 585 (Pubitemid 40204670)
31. D.A. Cohen, S.Y. Wu, and T.A. Farley Cost-effective allocation of government funds to prevent HIV infection Health Aff (Millwood) 24 2005 915 926 (Pubitemid 41058590)
32. Lasry A, Sansom SL, Hicks KA, et al. Modeling the impact of HIV prevention strategies in the United States. National HIV Prevention Conference; August 23-26, 2008; Atlanta, GA. Presentation number E08-2.
33. J. Hornberger, M. Holodniy, and K. Robertus A systematic review of cost-utility analyses in HIV/AIDS: implications for public policy Med Decis Making 27 2007 789 821 (Pubitemid 350136010)